期刊文献+

食管癌发生发展过程中TRAIL和Survivin蛋白的表达研究 被引量:3

Expression of TRAIL and Survivin Protein in Carcinogenesis and Development of Esophageal Carcinoma
下载PDF
导出
摘要 目的探讨食管癌发生发展过程中TRAILS、urvivin蛋白的表达及与食管癌病理特征的关系。方法采用免疫组化SP法对60例食管癌手术后大体标本中食管正常黏膜、单纯增生、不典型增生及浸润癌组织进行检测及分析。结果TRAIL蛋白从正常黏膜→单纯增生→不典型增生→浸润癌呈渐进性低表达,而Survivin蛋白则呈渐进性高表达。食管浸润癌组织中TRAIL蛋白的低表达与Survivin蛋白的高表达呈负相关(r=-0.480,P<0.01)。结论TRAIL和Survivin 2种蛋白参与了食管癌的发生发展,两者的表达失调导致了食管癌的发生。 Objective To detect the expressions of TRAIL and Survivin protein in different esophageal epithelial lesions, and analyze the relation between the expression of TRAIL and Survivin. Methods Immunohistochemistry was used to detect the expression of TRAIL and Survivin in 60 cases of esophageal carcinoma with different epithelial lesions including normal, heperplasia, displasia and invasive carcinoma. Results The expression of Survivin was progressively increased and that of TRAIL was decreased from normal to invasive carcinoma. The expression of TRAIL protein in esophageal invasive carcinoma was negatively correlated with that of Survivin protein ( r = - 0. 480, P 〈 0.01 ). Conclusions The expression of TRAIL and Survivin is significantly related to the genesis and progression of esophageal carcinoma.
出处 《河南肿瘤学杂志》 2005年第5期305-306,共2页 Henan Journal of Oncology
关键词 食管癌 肿瘤坏死因子相关的凋亡诱导配体 凋亡抑制基因 esophageal carcinoma TRAII Survivin
  • 相关文献

参考文献7

二级参考文献43

  • 1王康敏,杨军,黄莺,陈晓黎,孙润芹,张镁.THE EXPRESSION OF BCL-2 AND BAX PROTEINS IN GASTRIC CARCINOMA AND PRECANCEROUS LESIONS[J].Academic Journal of Xi'an Jiaotong University,2001(1):56-58. 被引量:1
  • 2Takahashi R, Deveraux Q, Tamm I, et al. A single BIR domain of XIAP sufficient for inhibiting caspases. J Biol Chem, 1998,273: 7787- 7790.
  • 3Ambrosini G, Adida C, Sirugo G, et al. Induction of apoptosis and inhibition of cell proliferation by survivin gene targeting. J Biol Chem, 1998,273:11177-11182.
  • 4Ambrosini G, Adida C,Altieri DC. A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med,1997,3:917-921.
  • 5Mahotka C, Wenzel M, Springer E, et al. survivin-deltaEx3 and survivin-2B: two novel splice variants of the apoptosis inhibitor survivin with different antiapoptotic properties. Cancer Res, 1999, 59:6097-6102.
  • 6Zhao J, Tenev T, Martins LM, et al. The ubiquitin-proteasome pathway regulates survivin degradation in a cell cycle-dependent manner. J Cell Sci, 2000, 113 (Pt 23): 4363-4371.
  • 7Li F, Ambrosini G, Chu EY,et al. Control of apoptosis and mitotic spindle checkpoint by survivin. Nature, 1998, 396:580-584.
  • 8Suzuki A, Ito T, Kawano H, et al. survivin initiates procaspase 3/p21 complex formation as a result of interaction with Cdk4 to resist Fas-mediated cell death. Oncogene 2000, 19: 1346-1353.
  • 9O′Connor DS, Grossman D, Plescia J, et al. Regulation of apoptosis at cell division by p34cdc2 phosphorylation of survivin. Proc Natl Acad Sci U S A, 2000, 97:13103-13107.
  • 10Shin S, Sung BJ, Cho YS, et al. An anti-apoptotic protein human survivin is a direct inhibitor of caspase-3 and -7. Biochemistry , 2001, 40:1117-1123.

共引文献60

同被引文献13

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部